CCR4-dependent regulatory T cell function in inflammatory bowel disease

被引:111
|
作者
Yuan, Qian
Bromley, Shannon K.
Means, Terry K.
Jones, Krister J.
Hayashi, Fumitaka
Bhan, Atul K.
Luster, Andrew D. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis,Div Rheumatol A, Boston, MA 02114 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pediat,Div Pediat Gastroenterol & Nutr, Boston, MA 02114 USA
[3] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02114 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2007年 / 204卷 / 06期
关键词
D O I
10.1084/jem.20062076
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inflammatory bowel disease (IBD) is an idiopathic inflammatory disease of the intestine. CD4(+) T lymphocytes play an important role in both initiating and regulating intestinal inflammatory immune responses. CD4(+) CD25(+)CD45RB(low) regulatory T (T reg) cells are capable of preventing the development of colitis in a mouse model of IBD. The precise mechanism of T reg cell - mediated prevention of colitis in this model is unclear, and the role of chemokine receptors in the trafficking and function of T reg cells in this model has not been determined. We examined the role of the chemokine receptor CCR4 in in vivo trafficking and suppressive function of T reg cells in a mouse adoptive transfer model of IBD. CCR4-deficient T reg cells failed to accumulate in the mesenteric lymph nodes (MLNs) at early time points (2 - 5 d) after adoptive transfer, resulting in a failure to suppress the generation of pathogenic T cells and the development of colitis. Moreover, although CCR4-deficent T cells had equivalent in vitro suppressive activity and accumulated in MLNs at later time points (42 - 56 d), they were unable to suppress colitis. Our study demonstrates that CCR4 plays an important role in T reg cell trafficking in LNs and that this is critical for T reg cell suppressive function in vivo.
引用
收藏
页码:1327 / 1334
页数:8
相关论文
共 50 条
  • [41] Peripheral and intestinal regulatory CD4+CD25high T cells in inflammatory bowel disease
    Maul, J
    Loddenkemper, C
    Mundt, P
    Berg, E
    Giese, T
    Stallmach, A
    Zeitz, M
    Duchmann, R
    GASTROENTEROLOGY, 2005, 128 (07) : 1868 - 1878
  • [42] Peripheral and Intestinal CD4+ T Cells With a Regulatory Phenotype in Pediatric Patients With Inflammatory Bowel Disease
    La Scaleia, Raffaella
    Morrone, Stefania
    Stoppacciaro, Antonella
    Scarpino, Stefania
    Antonelli, Manila
    Bianchi, Elettra
    Di Nardo, Giovanni
    Oliva, Salvatore
    Viola, Franca
    Cucchiara, Salvatore
    Santoni, Angela
    Palmieri, Gabriella
    Uccini, Stefania
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 51 (05): : 563 - 572
  • [43] Hepatosplenic T-cell lymphoma and inflammatory bowel disease
    Thai, Anne
    Prindiville, Thomas
    JOURNAL OF CROHNS & COLITIS, 2010, 4 (05): : 511 - 522
  • [44] Hepatosplenic T-cell lymphoma and inflammatory bowel disease
    Gutierrez-Rios, Laura
    Vayreda, Eva
    Calafat, Margalida
    Manosa, Miriam
    Domenech, Eugeni
    Canete, Fiorella
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2024, 116 (03) : 175 - 175
  • [45] Dysregulation of T cell response in the pathogenesis of inflammatory bowel disease
    Chandwaskar, Rucha
    Dalal, Rajdeep
    Gupta, Saurabh
    Sharma, Aishwarya
    Parashar, Deepak
    Kashyap, Vivek K.
    Sohal, Jagdip Singh
    Tripathi, Subhash K.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2024, 100 (06)
  • [46] Targeting T-cell migration in inflammatory bowel disease
    Marsal, J.
    Agace, W. W.
    JOURNAL OF INTERNAL MEDICINE, 2012, 272 (05) : 411 - 429
  • [47] Absence of CCR4 enhances the function of expanded regulatory T-cells
    Coghill, James M.
    Seidel, Hans
    Serody, Jonathan S.
    BLOOD, 2007, 110 (11) : 646A - 646A
  • [48] T Cell Lymphoma of the Colon Presenting as Inflammatory Bowel Disease
    Cheung, Derrick
    Tin, Jack
    Li, JianJun
    Tenner, Scott
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S360 - S360
  • [49] T-cell modulating antibodies in inflammatory bowel disease
    Baumgart, D. C.
    Immunoregulation in Inflammatory Bowel Diseases - Current Understanding and Innovation, 2007, 153 : 194 - 201
  • [50] Neutrophil-T cell crosstalk in inflammatory bowel disease
    Kvedaraite, Egle
    IMMUNOLOGY, 2021, 164 (04) : 657 - 664